Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Motif shares in the US are starting to tick up.
All fingers crossed for Motif multibagging. This with leverage will give us a much greater advantage if it 3 bags or more. It’s worrh a punt. If it doesn’t get approval AMP are totally screwed. But looks like Motif are confident.
I think this number crunching is rather pointless at this stage as let’s be real - if motif get FDA approval, a lot of people will be buying into both and will hoping to get on a nice spike and bail out with decent profit. Once that RNS comes through, if good, the sp here will rise a fair amount. The MMs won’t get their pen and papers out and calculate how much debt etc they have and think “ah okay great RNS at Motif, let’s keep it as 1.8 because that balances their books”. Market dynamics will play its role and its going to go up here if there’s good news, we just don’t know by how much.
Amphion's interims (view the detailed financial report addendum 10..), total liabilities are $29,053,470 (£22.44m) that includes convertible promissory notes, promissory notes, and several loan facilities. This figure excludes monies owed to the directors of $4.5m (£3.48m). If you then add the directors' monies to the £22.44m you arrive at £25.92m. Now, applying mandatory routine fiscal adjustments (cash burn and interest payments on the liabilities) gives a projected debt value of £27.4m.
It’s not “debt free” until all debts and loans paid off. Simples Assets would need to be sold
Debt is around 22m.
At mtfb = 70p (200m mcap) - amp is debt free.
All very positive
Gl
was by 13th. Maybe Motif already has a decision and is writing the RNS right now
That’s what people are looking at. The problem is they don’t delve deep enough to see AMP. Might have £15m worth or investments. They also have around £27 million debt. This could still multibag. IF Motif 3 bags or more. Work it out. It’s still definitely worth a punt if you believe Motif will multibag.
So that adds up to fag pack maths of around £15million worth of investments AMP. Have.
And the others are on the books maybe up to a couple of million.
It’s 18% but that’s just splitting hairs. We also own £10million worth of Motif at today’s prices.
Nothing in the market makes sense! Just go with the flow!
We are the largest shareholder of polx owning 23% which equates to 3.9m. Now look at the market cap!!
Current mcap vs current debt? Mmm not sure how you get that one liquid Share price “factoring it in” isn’t correct. Look at mcap and debt which is more accurate of over or under valued in my eyes The biggest rise with be on motif imo But I’m in both so makes no odds as long as approved
Rise 'cause we are worth 10m Mcap based on 8.8% holding, and current Mcap is 3.8m!
All those debts were factored in by the market @0.57p!
Enough said!
Roll on Approval of MRSA resistant antibiotic! AKA Iclaprim!
News imminent
Gl
Why?
Expecting similar type on the news
Motif up 2percent. Amp 15 percent.
Mannn is not “if” it’s near on impossible for a 7am rns given the fda meeting will be during the working day tomrorow and you have US markets to consider
This was also falling in the morning
If no rns at 7.am. Then it could be at anytime who knows
And motif falling away and likely to finish about flat Too many getting carried away imo
The approval won’t be until intra day tomrorow if approved so those expecting 7am rns will be disappointed. Likely intra day PM or Thursday imo Imo
Any good news and this will open 100 percent up before any buy take place